References
- Alomari M.M.M., Dec M., Nowaczek A., Puchalski A., Wernicki A., Kowalski C.J., Urban-Chmiel R.: Therapeutic and Prophylactic Effect of the Experimental Bacteriophage Treatment to Control Diarrhea Caused by E. coli in Newborn Calves. ACS Infect Dis 2021, 7, 2093–2101, doi: 10.1021/acsinfecdis.1c00010.
- Awad W.S., El-Sayed A.A., Mohammed F.F., Bakry N.M., Abdou N.M.I., Kamel M.S.: Molecular characterization of pathogenic Escherichia coli isolated from diarrheic and in-contact cattle and buffalo calves. Trop Anim Health Prod 2020, 52, 3173–3185, doi: 10.1007/s11250-020-02343-1.
- Barr J.J.: A bacteriophages journey through the human body. Immunol Rev 2017, 279, 106–122, doi: 10.1111/imr.12565.
- Batinovic S., Wassef F., Knowler S.A., Rice D.T.F., Stanton C.R., Rose J., Tucci J., Nittami T., Vinh A., Drummond G.R., Sobey C.G., Chan H.T., Seviour R.J., Petrovski S., Franks A.E.: Bacteriophages in Natural and Artificial Environments. Pathogens 2019, 8, 100, doi: 10.3390/pathogens8030100.
- Bochkareva E.V., Butina E.K., Kim I.V., Kontsevaya A.V., Drapkina O.M., Leon D., McKee M.: Adherence to antihypertensive medication in Russia: a scoping review of studies on levels, determinants and intervention strategies published between 2000 and 2017. Arch Public Health 2019, 77, 43, doi: 10.1186/s13690-019-0366-9.
- Clark J.R., March J.B.: Bacteriophages and biotechnology: vaccines, gene therapy and antibacterials. Trends Biotech 2006, 24, 212–218, doi: 10.1016/j.tibtech.2006.03.003.
- Dąbrowska K., Miernikiewicz P., Piotrowicz A., Hodyra K., Owczarek B., Lecion D., Kaźmierczak Z., Letarov A., Górski A.: Immunogenicity studies of proteins forming the T4 phage head surface. J Virol 2014, 88, 12551–12557, doi: 10.1128/JVI.02043-14.
- Dec M., Wernicki A., Urban-Chmiel R.: Efficacy of experimental phage therapies in livestock. Anim Health Res Rev 2020, 21, 69–83, doi: 10.1017/S1466252319000161.
- Duerkop B.A., Clements C.V., Rollins D., Rodrigues J.L., Hooper L.V.: A composite bacteriophage alters colonization by an intestinal commensal bacterium. Proc Natl Acad Sci USA 2012, 109, 17621–17626, doi: 10.1073/pnas.1206136109.
- Górski A., Jończyk-Matysiak E., Łusiak-Szelachowska M., Międzybrodzki R., Weber-Dąbrowska B., Borysowski J.: Phage therapy in allergic disorders? Exp Biol Med 2018, 243, 534–537, doi: 10.1177/1535370218755658.
- Górski A., Międzybrodzki R., Borysowski J., Dąbrowska K., Wierzbicki P., Ohams M., Korczak-Kowalska G., Olszowska-Zaremba N., Łusiak-Szelachowska M., Kłak M., Jończyk E., Kaniuga E., Gołaś A., Purchla S., Weber-Dąbrowska B., Letkiewicz S., Fortuna W., Szufnarowski K., Pawełczyk Z., Rogóż P., Kłosowska D.: Chapter 2, Phage as a modulator of immune responses: practical implications for phage therapy. In: Advances in Virus Research, vol. 83, edited by M. Łobocka, W. Szybalski, Academic Press, London, 2012, pp. 41–47, doi: 10.1016/B978-0-12-394438-2.00002-5.
- Hodyra-Stefaniak K., Miernikiewicz P., Drapała J., Drab M., Jończyk-Matysiak E., Lecion D., Kaźmierczak Z., Beta W., Majewska J., Harhala M., Bubak B., Kłopot A., Górski A., Dąbrowska K.: 2015. Mammalian Host-Versus-Phage immune response determines phage fate in vivo. Sci Rep 2015, 5, 14802, doi: 10.1038/srep14802.
- Huff W.E., Huff G.R., Rath N.C., Balog J.M., Donoghue A.M.: Prevention of Escherichia coli infection in broiler chickens with a bacteriophage aerosol spray. Poultry Sci 2002, 81, 1486–1491, doi: 10.1093/ps/81.10.1486.
- Krut O., Bekeredjian-Ding I.: Contribution of the Immune Response to Phage Therapy. J Immunol 2018, 200, 3037–3044, doi: 10.4049/jimmunol.1701745.
- Laemmli U.K.: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227, 680–685, doi: 10.1038/227680a0.
- Lin D.M., Koskella B., Lin H.C.: Phage therapy: An alternative to antibiotics in the age of multi-drug resistance. World J Gastrointest Pharmacol Ther 2017, 8, 162–173, doi: 10.4292/wjgpt.v8.i3.162.
- Ly-Chatain M.H.: The factors affecting effectiveness of treatment in phages therapy. Front Microbiol 2014, 5, 1–7, doi: 10.3389/fmicb.2014.00051.
- Łusiak-Szelachowska M., Żaczek M., Weber-Dąbrowska B., Międzybrodzki R., Kłak M., Fortuna W., Letkiewicz S., Rogóż P., Szufnarowski K., Jończyk-Matysiak E., Owczarek B., Górski A.: Phage neutralization by sera of patients receiving phage therapy. Viral Immunol 2014, 27, 295–304, doi: 10.1089/vim.2013.0128.
- Majewska J., Kaźmierczak Z., Lahutta K., Lecion D., Szymczak A., Miernikiewicz P., Drapała J., Harhala M., Marek-Bukowiec K., Jędruchniewicz N., Owczarek B., Górski A., Dąbrowska K.: Induction of Phage-Specific Antibodies by Two Therapeutic Staphylococcal Bacteriophages Administered per os. Front Immunol 2019, 10, 2607, doi: 10.3389/fimmu.2019.02607.
- Manohar P.M., Tamhankar A.J., Leptihn S., Ramesh N.: Pharmacological and Immunological Aspects of Phage Therapy. Infect Microbes Dis 2019, 1, 34–42, doi: 10.1097/IM9.0000000000000013.
- Mohammed S., Marouf S., Erfana A.M., El-Jakee J., Hessain A.M., Dawoud T.M., Kabli S.A., Moussa I.M.: Risk factors associated with E. coli causing neonatal calf diarrhea. Saudi J Biol Sci 2019, 26, 1084–1088, doi: 10.1016/j.sjbs.2018.07.008.
- Nguyen S., Baker K., Padman B.S., Patwa R., Dunstan R.A., Weston T.A., Schlosser K., Bailey B., Lithgow T., Lazarou M., Luque A., Rohwer F., Blumberg R.S., Barr J.J.: Bacteriophage transcytosis provides a mechanism to cross epithelial cell layers. mBio 2017, 8, e01874-17, doi: 10.1128/mBio.01874-17.
- Padalino B., Cirone F., Zappaterra M., Tullio D., Ficco G., Giustino A., Ndiana L.A., Pratelli A.: Factors Affecting the Development of Bovine Respiratory Disease: A Cross-Sectional Study in Beef Steers Shipped From France to Italy. Front Vet Sci 2021, 8, 627894, doi: 10.3389/fvets.2021.627894.
- Principi N., Silvestri E., Esposito S.: Advantages and Limitations of Bacteriophages for the Treatment of Bacterial Infections. Front Pharmacol 2019, 10, 513, doi: 10.3389/fphar.2019.00513.
- Suttle C.A.: Marine viruses – major players in the global ecosystem. Nat Rev Microbiol 2007, 5, 801–812, doi: 10.1038/nrmicro1750.
- Urban-Chmiel R., Wernicki A., Dec M., Puchalski A., Nowaczek A., Marek A., Stępień-Pyśniak D.: Method of preparing a composition in the form of a suspension for the treatment of respiratory syndrome involving Mannheimia haemolytica in cattle. Polish Patent No. 240083. Urząd Patentowy Rzeczypospolitej Polskiej, Warsaw, 8/03/2021 Wiadomości Urządu Patentowego 05/21.
- Urban-Chmiel R., Wernicki A., Stęgierska D., Dec M., Dudzic A., Puchalski A.: Isolation and Characterization of Lytic Properties of Bacteriophages Specific for M. haemolytica Strains. PLoS One 2015, 10, e0140140, doi: 10.1371/journal.pone.0140140.
- Urban-Chmiel R., Wernicki A., Stęgierska D., Dudzic A., Puchalski A., Dec M.: Wykorzystanie bakteriofagów w zwalczaniu zakażeń wywoływanych u bydła przez M. haemolytica (The application of bacteriophages in combatting cattle infections caused by M. haemolytica – in Polish). Lecz Dużych Zwierz 2014, 9, Monograph 2, 23–25.
- Urban-Chmiel R., Wernicki A., Wawrzykowski J., Puchalski A., Nowaczek A., Dec M., Stęgierska D., Alomari M.M.M.: Protein profiles of bacteriophages of the family Myoviridae‑like induced on M. haemolytica. AMB Express 2018, 8, 102, doi: 10.1186/s13568-018-0630-3.
- Wernicki A., Urban-Chmiel R., Balicki I., Świąder K., Dec M., Puchalski A., Nowaczek A., Stęgierska D., Marek A., Pyzik E., Stępień-Pyśniak D., Poleszak E.: Method of producing a preparation for treatment of bacterial conjunctivitis. Polish Patent No. 235994, Urząd Patentowy Rzeczypospolitej Polskiej, Warsaw, 02/07/2020.
- Wernicki A., Urban-Chmiel R., Dec M., Puchalski A., Nowaczek A., Stęgierska D., Kowalski C.: Phage-probiotic preparation that is applied in preventive treatment of diarrhea in cattle, caused by E. coli strains and method for obtaining the phage-probiotic preparation. Polish Patent No. 236941. Urząd Patentowy Rzeczypospolitej Polskiej, Warsaw, 04/11/2020.
- Żaczek M., Łusiak-Szelachowska M., Jończyk-Matysiak E., Weber-Dąbrowska B., Międzybrodzki R., Owczarek B., Kopciuch A., Fortuna W., Rogóż P., Górski A.: Antibody production in response to staphylococcal MS-1 phage cocktail in patients undergoing phage therapy. Front Microbiol 2016, 7, 1681, doi: 10.3389/fmicb.2016.01681.
- Żaczek M., Łusiak-Szelachowska M., Weber-Dąbrowska B., Międzybrodzki R., Fortuna W., Rogóż P., Letkiewicz S., Górski A.: Humoral Immune Response to Phage-Based Therapeutics. In: Phage Therapy: A Practical Approach, edited by A. Górski, R. Międzybrodzki, J. Borysowski, Springer Nature Switzerland, Cham, 2019, pp. 123–143, doi: 10.1007/978-3-030-26736-0_5.